survodutide mastery course
Unit 5 of 12
MASH and Liver Disease
from fatty liver to fibrosis: what survodutide does differently
The Liver Disease Opportunity
Metabolic dysfunction-associated steatohepatitis (MASH) affects millions and has limited treatment options. Survodutide's glucagon component drives direct hepatic effects that GLP-1-only agonists cannot match. This unit covers the disease progression, the Phase 2 biopsy data, and the fibrosis signal.
Interactive Liver Pathology
Trace the progression from healthy liver through steatosis, inflammation, and fibrosis.
liver pathology progression